New AI-powered solution transforms dossier creation and maintenance with source-level traceability, cross-functional collaboration, and up to 70% faster authoring and updates
CAMBRIDGE, Mass., Oct. 27, 2026 /PRNewswire-PRWeb/ -- MadeAi™, a leader in AI-enabled evidence synthesis and life sciences solutions, today announced the launch of MadeAi Dossier Expert, a new AI-powered solution designed to transform how pharmaceutical and life sciences organizations create, review, and maintain formulary and value dossiers.
Traditionally, developing AMCP dossiers, global value dossiers, and health technology assessment (HTA) submissions requires months of coordination across HEOR, Clinical, Market Access, and Medical Writing teams. Evidence is dispersed across multiple sources, citations require extensive manual verification, and updates often trigger lengthy rounds of rewriting and review.
Dossier Expert replaces this fragmented process with a living, evidence-linked document that evolves as the underlying science changes.
Built to address one of the most time-consuming challenges facing Market Access and HEOR teams, Dossier Expert brings evidence management, AI-assisted authoring, citation verification, and cross-functional collaboration into a single, continuously updated environment.
From Static Documents to Living Evidence
Unlike traditional dossier authoring approaches that focus primarily on accelerating initial drafts, Dossier Expert is designed to streamline the entire dossier lifecycle—from first creation through ongoing evidence updates.
Key capabilities include:
- AI-Powered Dossier Generation: Create structured AMCP, HTA, and value dossiers using customizable templates and AI-generated, evidence-grounded content.
- One-Click Citation Verification: Trace every AI-generated claim directly to its source document, with the supporting passage highlighted for immediate verification.
- Intelligent Evidence Updates: Automatically identify sections affected by changes in underlying evidence and selectively regenerate outdated content without overwriting human edits.
- Integrated Evidence Hub: Organize and connect indexed source materials directly to relevant dossier sections.
- Integrated MadeAi-LR: Access AI-enabled literature review directly for in-platform literature review support.
- Seamless Collaboration: Enable HEOR, Clinical, Market Access, and Medical Writing teams to work within one document, with built-in commenting, assignments, approvals, and version control.
- Flexible, Submission-Ready Outputs: Export approved dossiers to Word or PDF.
Accelerating Market Access Without Compromising Scientific Rigor
Dossier Expert is designed to deliver up to 70% faster dossier authoring and updates, while reducing the manual effort associated with evidence verification, document management, and recurring revisions.
"Creating a dossier is only part of the challenge. Keeping it scientifically current, fully traceable, and aligned across multiple stakeholders is where organizations lose enormous amounts of time," said Gaugarin Oliver, Founder and CEO of MadeAi. "With Dossier Expert, we're moving beyond AI-generated first drafts to a fundamentally different model: a living dossier that connects every claim to its evidence, identifies what needs updating, and enables experts to focus on scientific judgment rather than document administration."
By combining AI-powered efficiency with human oversight and transparent source verification, Dossier Expert helps life sciences organizations accelerate evidence communication while maintaining the rigor required for payer and HTA engagement.
Learn more about Dossier Expert at www.madeai.com.
About MadeAi
MadeAi™ is an award-winning AI-native evidence synthesis and life sciences solutions platform designed to help pharmaceutical, biotechnology, and medical device organizations accelerate evidence generation and scientific communication. Combining advanced agentic AI capabilities with human expertise, MadeAi supports workflows across HEOR, Market Access, Medical Affairs, and RWE, delivering greater efficiency, transparency, and scientific rigor.
Media Contact
Meghan Oates-Zalesky, MadeAi, 1 617 435 2470, [email protected], www.madeai.com
SOURCE MadeAi
Share this article